Icon plc
Advertisement
Articles by Icon plc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
2
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
3
Pharmaceutical Executive Daily: FDA Approves Simtriyo
4
argenx Acquires Forte Biosciences for $2.2 Billion
5